RANI NASDAQ
Rani Therapeutics Holdings, Inc.
1W: +6.8%
1M: -5.5%
3M: +2.2%
YTD: -40.4%
1Y: +59.3%
3Y: -71.0%
5Y: -95.5%
$0.81
+0.02 (+1.92%)
Weekly Expected Move ±9.7%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
5 relationships5
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-03-23
Earliest Filing
2025-10-17
Latest Filing
partner: 5
Counterparties (Filed by RANI)
5 relationshipsCompanies named in RANI's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | — | partner | Entered into a Collaboration and License Agreement to develop and commercialize a hemophilia product combining Chugai's | 2025-10-17 | View |
| ProGen Co., Ltd. | — | partner | Entered into a Collaboration Agreement with Rani Therapeutics to jointly develop, seek regulatory approval for, and comm | 2024-06-24 | View |
| Cantor Fitzgerald & Co. | — | partner | Agent for the Controlled Equity Sales Agreement | 2022-08-25 | View |
| H.C. Wainwright & Co., LLC | — | partner | Agent for the Controlled Equity Sales Agreement | 2022-08-25 | View |
| InCube Labs, LLC | — | partner | Partner in a lease space sharing agreement with Rani Therapeutics, LLC | 2022-03-23 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-04 | Officer/Director Change | View | |
| 2026-06-30 | Officer/Director Change; Exhibits | View | |
| 2026-05-29 | Shareholder Vote | View | |
| 2026-05-27 | Other Events; Exhibits | View | |
| 2026-05-15 | Earnings Release; Delisting Notice; Officer/Director Change; Exhibits | View | |
| 2026-03-26 | Earnings Release; Exhibits | View | |
| 2026-01-02 | Termination of Material Definitive Agreement; Material Modification to Rights of Security Holders; A | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-27 | Departure/Election of Directors; Appointment of Officers; Other Events | View | |
| 2025-10-17 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-16 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-26 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-05-29 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-20 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2025-05-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-06 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View | |
| 2025-04-30 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-04-09 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR